Morfina taldea - Euskara

Bibliografia
Lord J, Waterfield A, Hughes J, Kosterlitz H, 1977. Endogenous opioid peptides: Multiple
agonists and receptors. Nature. 267: 495-499. 1977.
Lorenzo P, Ladero JM, Leza JC, Lizasoain I. Drogodependencias. Editorial
Panamericana. 1999.
Lynch DR, Snyder SH. Neuropeptides: multiple molecular forms, metabolic pathways and
receptors. Annu. Rev. Biochem. 55: 773-779. 1986.
Maldonado R, Blendy JA, Tzavara E, Gass P, Roques BP, Hanoune J, Schültz G.
Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science.
273: 657-659. 1996.
Maldonado R, Derrien M, Noble F, Roques BP. Association of the peptidase inhibitor RB
101 and a CCK-B antagonist strongly enhances antinociceptive responses. Neuroreport 4: 947-
950. 1993.
Maldonado R, Fournié-Zaluski MC, Roques BP. Attenuation of the morphine withdrawal
syndrome by inhibition of catabolism of endogenous enkephalins in the periacueductal gray matter.
Naunyn Schmiedebergs Arch Pharmacol. 345: 466-472. 1992.
Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC. High-affinity enkephalindegrading
peptidase in mouse brain and its enhanced activity following morphine. Nature. 276: 523-
526. 1978.
Mansour A 1 , Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ. Mu,
delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridisation study.
J. Comp. Neurol. 350(3): 412-438. 1994.
Mansour A 2 , Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ. Muopioid
receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res.
643: 245-265. 1994.
257
Doktore-tesia